Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patient death
Biotech
Kezar suspends key lupus study after 4 deaths
The voluntary hold comes after Kezar restructured last year to in a bid to support its lupus and hepatitis candidate zetomipzomib.
Zoey Becker
Sep 30, 2024 11:23am
Oncternal stock sinks 60% amid layoffs, trial terminations
Sep 12, 2024 10:51am
FDA places hold on Zentalis’ WEE1 drug after two sepsis deaths
Jun 18, 2024 8:21am
Pfizer faces phase 3 DMD fail after patient death
Jun 12, 2024 5:01pm
ASCO: J&J's radioligand spurs responses, but 4 deaths mar data
May 24, 2024 10:51am
Young participant in Pfizer's DMD gene therapy trial dies
May 7, 2024 4:29pm
